Chris Infotainment

A Breakthrough in Pancreatic Cancer Treatment Patients suffering from severe cancer often turn to large hospitals in Seoul for treatment. However, recent developments have shown that regional hub hospitals are also achieving remarkable results. One such case involves a 53-year-old woman who successfully underwent treatment for metastatic stage 4 pancreatic cancer at a regional hospital. Professor Choi Jong-kwon, from the Department of Hematology-Oncology at Konyang University Hospital, shared the findings of a study involving this patient. The case highlights the potential of combining traditional anticancer therapies with innovative immune cell treatments. The patient was diagnosed with stage 4 pancreatic cancer, which means the disease had already spread to other parts of the body, making surgery an impossible option. Pancreatic cancer is known for being one of the most challenging cancers to treat, with the lowest survival rate among all types of cancer. In advanced stages, the c...

The Rise of Radiotherapy in Rwanda: A Lifeline for Cancer Patients Since 2018, radiotherapy has become a critical component of cancer treatment in Rwanda, allowing patients to receive care closer to home. Before this development, many individuals had to travel to neighboring countries like Uganda or Kenya for treatment. Today, the Rwanda Cancer Centre (RCC) at the Rwanda Military Referral and Teaching Hospital in Kanombe provides essential radiotherapy services, supporting patients with various types of cancer. Dr. Theoneste Maniragaba, Director of the Cancer Programme at the Rwanda Biomedical Centre (RBC), highlights that approximately 60% of cancer patients globally require radiotherapy at some point during their treatment. This form of therapy can be used as a primary treatment, combined with surgery or chemotherapy, or as part of palliative care to alleviate symptoms and improve quality of life. Advancements in Local Treatment Prior to 2018, patients often faced the challenge o...

Breakthrough in Cancer Treatment: A New Approach to Reversing Cancer Cells A groundbreaking development has emerged from South Korea, where a research team has created the first-ever "molecular reversion switch" technology. This innovative approach has the potential to transform cancer cells back into a near-normal state, offering a new dimension in the fight against cancer. Unlike traditional treatments that aim to destroy cancer cells, this method is expected to significantly reduce side effects and provide a more fundamental solution. The National Cancer Center reported on the 9th that Professor Shin Dong-gwan from the Bioinformatics Research Division and Professor Cho Kwang-hyun from the Department of Bio and Brain Engineering at Korea Advanced Institute of Science and Technology (KAIST) have jointly developed a systems biology-based core technology called "REVERT." Systems biology combines IT technologies, mathematical modeling, and computer simulations with ...

Understanding the Evolution of Cancer Treatment Cancer is fundamentally a genetic disease. It arises when changes in a person's DNA, referred to as variants or mutations, disrupt normal cell functions such as growth and division. These changes can be inherited from families or acquired during a person's lifetime due to factors like smoking, ultraviolet radiation, and infectious agents. Over the past few decades, we've entered an era of personalised medicine. This approach involves tailoring cancer treatment to each patient's unique characteristics, considering their genetic and molecular make-up, overall health status, age, body composition, lifestyle habits, and use of other medications. As a result, the role of genetics in cancer treatment has become more prominent. The Role of Genetic Testing in Cancer Care Advances in DNA sequencing technologies have made it possible to detect genetic variants more quickly and accurately. These tests can look for just a few gene...